The product is GMP produced and is approved to be used in clinical trials and for other reasearch purposes.
Sodium orthophosphate, Na2H32PO4 for injection is a radiopharmaceutical intended for the treatment of primary polycythemica and primary polythrombocythemia when all alternative forms of treatment fail to produce results. It can also be used in treatment of leukemia and other hematologic diseases. The Na2H32PO4 can also be used as a painkiller in the bone metastases, but in such cases its toxicity for the bone marrow should be taken into consideration.
This medicinal product is for diagnostic use only. Fludeoxyglucose (18F) is intended for use with positron emission tomography (PET). We deliver FDG from the cyclotron in Berlin, and it is available in Sweden only. FDG Eckert & Ziegler is a registered radiopharmaceutical since 2008